Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community

Vaccine

Volumn 30, Issue 30, 2012, Pages 4511-4516

  Javanbakht, Marjan ^a   Stahlman, Shauna ^a   Walker, Susan ^b   Gottlieb, Sami ^c   Markowitz, Lauri ^c   Liddon, Nicole ^c   Plant, Aaron ^b   Guerry, Sarah ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sexually Transmitted Disease Program   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HPV; Medical provider; Qualitative research; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; ATTITUDE TO HEALTH; CLINICAL ARTICLE; HEALTH BEHAVIOR; HEALTH BELIEF; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH PROGRAM; HIGH RISK POPULATION; HISPANIC; HUMAN; IMMUNIZATION; INTERVIEW; MEDICAL STAFF; MOTHER; PARENTAL ATTITUDE; PEER GROUP; PERCEPTION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UTERINE CERVIX CANCER; VACCINATION;

ADOLESCENT; ATTITUDE OF HEALTH PERSONNEL; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HEALTH SERVICES ACCESSIBILITY; HISPANIC AMERICANS; HUMANS; LOS ANGELES; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; PERCEPTION; PHYSICIAN'S PRACTICE PATTERNS; VACCINATION;

EID: 84862003439     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.062     Document Type: Article

References (46)

1. Hariri S., Unger E.R., Sternberg M., Dunne E.F., Swan D., Patel S., et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. Journal of Infectious Diseases 2011, 204(August (4)):566-573.
2. Koutsky L. Epidemiology of genital human papillomavirus infection. American Journal of Medicine 1997, 102(May (5A)):3-8.
3. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochimica et Biophysica Acta 1996, 1288(October (2)):F55-F78.
4. Howlader NN, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2008. National Cancer Institute. Bethesda, MD: based on November 2010 SEER data submission, posted to the SEER web site, 2011. http://seer.cancer.gov/csr/1975_2008/.
5. Food and Drug Administration Product approval information-licensing action [package insert]. Gardasil (quadrivalent human papillomavirus types 6,11,16, and 18) 2006, Merck and Co., Whitehouse Station, NJ, Available at .
6. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Paavonen J., Iversen O.E., et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer 2006, 95(December (11)):1459-1466.
7. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR: Recommendations and Reports 2007, 56(March (RR-2)):1-24.
8. Centers for Disease Control and Prevention Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 2011, 60(December (50)):1705-1708.
9. Constantine N.A., Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. Journal of Adolescent Health 2007, 40(February (2)):108-115.
10. Scarinci I.C., Garces-Palacio I.C., Partridge E.E. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. Journal of Womens Health (Larchmt) 2007, 16(October (8)):1224-1233.
11. Bair R.M., Mays R.M., Sturm L.A., Zimet G.D. Acceptability of the human papillomavirus vaccine among Latina mothers. Journal of Pediatric and Adolescent Gynecology 2008, 21(December (6)):329-334.
12. Watts L.A., Joseph N., Wallace M., Rauh-Hain J.A., Muzikansky A., Growdon W.B., et al. HPV vaccine: a comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecologic Oncology 2009, 112(March (3)):577-582.
13. Bastani R., Glenn B.A., Tsui J., Chang L.C., Marchand E.J., Taylor V.M., et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiology Biomarkers & Prevention 2011, 20(July (7)):1463-1472.
14. Graham J.E., Mishra A. Global challenges of implementing human papillomavirus vaccines. International Journal for Equity in Health 2011, 10(1):27.
15. Downs L.S., Scarinci I., Einstein M.H., Collins Y., Flowers L. Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecologic Oncology 2010, 117(June (3)):486-490.
16. Guerry S.L., De Rosa C.J., Markowitz L.E., Walker S., Liddon N., Kerndt P.R., et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011, 29(March (12)):2235-2241.
17. Allen J.D., Othus M.K., Shelton R.C., Li Y., Norman N., Tom L., et al. Parental decision making about the HPV vaccine. Cancer Epidemiology Biomarkers & Prevention 2010, 19(September (9)):2187-2198.
18. Bednarczyk R.A., Birkhead G.S., Morse D.L., Doleyres H., McNutt L.A. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine 2011, 29(April (17)):3138-3143.
19. Williams K., Forster A., Marlow L., Waller J. Attitudes towards human papillomavirus vaccination: a qualitative study of vaccinated and unvaccinated girls aged 17-18 years. Journal of Family Planning and Reproductive Health Care 2011, 37(January (1)):22-25.
20. Brewer N.T., Gottlieb S.L., Reiter P.L., McRee A.L., Liddon N., Markowitz L., et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sexually Transmitted Diseases 2011, 38(March (3)):197-204.
21. Gottlieb S.L., Brewer N.T., Sternberg M.R., Smith J.S., Ziarnowski K., Liddon N., et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. Journal of Adolescent Health 2009, 45(November (5)):430-437.
22. Luque J.S., Castaneda H., Martinez Tyson D., Vargas N., Meade C.D. Formative research on HPV vaccine acceptability among latina farmworkers. Health Promotion Practice 2011, (August).
23. Luque J.S., Castaneda H., Tyson D.M., Vargas N., Proctor S., Meade C.D. Hpv Awareness among Latina Immigrants and Anglo American Women in the Southern U.S.: Cultural Models of Cervical Cancer Risk Factors and Beliefs. NAPA Bulletin 2010, 34(November (1)):84-104.
24. Fernandez M.E., McCurdy S.A., Arvey S.R., Tyson S.K., Morales-Campos D., Flores B., et al. HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethnicity and Health 2009, 14(December (6)):607-624.
25. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. Journal of Adolescent Health 2005, 37(December (6)):502-510.
26. Tissot A.M., Zimet G.D., Rosenthal S.L., Bernstein D.I., Wetzel C., Kahn J.A. Effective strategies for HPV vaccine delivery: the views of pediatricians. Journal of Adolescent Health 2007, 41(August (2)):119-125.
27. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., et al. Attitudes about human papillomavirus vaccine among family physicians. Journal of Pediatric and Adolescent Gynecology 2005, 18(December (6)):391-398.
28. Mays R.M., Zimet G.D. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sexually Transmitted Diseases 2004, 31(July (7)):428-432.
29. McCave E.L. Influential factors in HPV vaccination uptake among providers in four states. Journal of Community Health 2010, 35(December (6)):645-652.
30. Keating K.M., Brewer N.T., Gottlieb S.L., Liddon N., Ludema C., Smith J.S. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. Journal of Adolescent Health 2008, 43(October (4 Suppl.)):S61-S67.
31. Glaser B.G., Strauss A.L. The discovery of grounded theory; strategies for qualitative research 1967, Aldine Pub. Co., Chicago.
32. Rand C.M., Shone L.P., Albertin C., Auinger P., Klein J.D., Szilagyi P.G. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Archives of Pediatrics & Adolescent Medicine 2007, 161(March (3)):252-259.
33. Rand C.M., Szilagyi P.G., Albertin C., Auinger P. Additional health care visits needed among adolescents for human papillomavirus vaccine delivery within medical homes: a national study. Pediatrics 2007, 120(September (3)):461-466.
34. Yeganeh N., Curtis D., Kuo A. Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates. Vaccine 2010, 28(June (25)):4186-4191.
35. Barnack J.L., Reddy D.M., Swain C. Predictors of parents' willingness to vaccinate for human papillomavirus and physicians' intentions to recommend the vaccine. Womens Health Issues 2010, 20(January-February (1)):28-34.
36. Mortensen G.L. Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health 2010, 10:68.
37. Perkins R.B., Pierre-Joseph N., Marquez C., Iloka S., Clark J.A. Why do low-income minority parents choose human papillomavirus vaccination for their daughters?. Journal of Pediatrics 2010, 157(October (4)):617-622.
38. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010, 126(September (3)):425-433.
39. Brewer N.T., Cuite C.L., Herrington J.E., Weinstein N.D. Risk compensation and vaccination: can getting vaccinated cause people to engage in risky behaviors?. Annals of Behavioral Medicine 2007, 34(August (1)):95-99.
40. Smoak N.D., Scott-Sheldon L.A., Johnson B.T., Carey M.P. Sexual risk reduction interventions do not inadvertently increase the overall frequency of sexual behavior: a meta-analysis of 174 studies with 116,735 participants. Journal of Acquired Immune Deficiency Syndrome 2006, 41(March (3)):374-384.
41. Larkey L. Las mujeres saludables: reaching Latinas for breast, cervical and colorectal cancer prevention and screening. Journal of Community Health 2006, 31(February (1)):69-77.
42. Hunter J.B., de Zapien J.G., Papenfuss M., Fernandez M.L., Meister J., Giuliano A.R. The impact of a promotora on increasing routine chronic disease prevention among women aged 40 and older at the U.S.-Mexico border. Health Education & Behavior 2004, 31(August (4 Suppl.)):18S-28S.
43. Livaudais J.C., Coronado G.D., Espinoza N., Islas I., Ibarra G., Thompson B. Educating Hispanic women about breast cancer prevention: evaluation of a home-based promotora-led intervention. Journal of Womens Health (Larchmt) 2010, 19(November (11)):2049-2056.
44. Balcazar H.G., Byrd T.L., Ortiz M., Tondapu S.R., Chavez M. A randomized community intervention to improve hypertension control among Mexican Americans: using the promotoras de salud community outreach model. Journal of Health Care for the Poor and Underserved 2009, 20(4):1079-1094.
45. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29(January (5)):890-895.
46. Kharbanda E.O., Stockwell M.S., Fox H.W., Andres R., Lara M., Rickert V.I. Text message reminders to promote human papillomavirus vaccination. Vaccine 2011, 29(March (14)):2537-2541.